Skip to content
bluejethealthcare.com
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Investor Presentation
Stock Exchange Communication
Material Contracts
Group Company Financials
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Draft letter of appointment of Independent Directors
Initial Public Offer
Prospectus
Industry Reports
Investors Contact
Menu
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Investor Presentation
Stock Exchange Communication
Material Contracts
Group Company Financials
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Draft letter of appointment of Independent Directors
Initial Public Offer
Prospectus
Industry Reports
Investors Contact
Consolidated Annual Report
Consolidated Annual Report FY 20-21
Consolidated Annual Report FY 19-20
FY 23-24
Q2 23-24
Financial Results September 23
Consolidated Annual Report
Consolidated Annual Report FY 20-21
Consolidated Annual Report FY 19-20
Consolidated Annual Report
Annual Report FY 20-21
Standalone Annual report
Restated Financial Statement : March 21 – June 23
Standalone Annual report FY 22-23
Standalone Annual report FY 21-22
Standalone Annual Report FY 20-21
Standalone Annual Report FY 19-20
Standalone Annual Report
Financials June-23
Annual Report FY 22-23
Annual Report FY 21-22
Annual Report FY 20-21
Scroll to Top